{
  "title": "Tertiary lymphoid structures potentially promote immune checkpoint inhibitor response in SMARCB1-deficient medullary renal cell carcinoma.",
  "pmid": "39543276",
  "doi": null,
  "affiliations": [
    "Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.",
    "Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.",
    "Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.",
    "Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.",
    "Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.",
    "Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.",
    "Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.",
    "Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.",
    "Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.",
    "Department of Pathology, West China Hospital, Sichuan University, Chengdu, China. chenni1@163.com.",
    "Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. sungx077@126.com.",
    "Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. kucaizeng@163.com."
  ]
}